Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals

Sponsor
University of Aarhus (Other)
Overall Status
Recruiting
CT.gov ID
NCT04865185
Collaborator
(none)
60
1
2
12
5

Study Details

Study Description

Brief Summary

The purpose of the present study is to systematically test the occurrence of paradoxical and illusory responses to cold and warm stimuli in healthy volunteers with artificial sensory loss.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Xylocaine spray 100mg/ml
  • Diagnostic Test: Ethanol
N/A

Detailed Description

Efficient thermal sensation is important for adequate behavioral response to cold or warm stimuli and early signs of neuropathy can be changes in the thermal sensation.

Alterations in thermal perception can results in paradoxical heat sensation (a warm perception when the skin is cooled) or a peculiar/burning sensation when the skin is stiumlated with simultaneous warm and cold (a "thermal grill").

Clarifying the occurrence of these paradoxical and illusory sensations, may help understanding early signs of peripheral neuropathy as well as thermal sensory perception.

The investigators plan to conduct a study on thermal sensory perception using a model of sensory loss in healthy volunteers and systematically test the occurrence of paradoxical heat sensations and responses to the thermal grill.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Diagnostic
Official Title:
Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals - a Randomized Crossover Trial
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Feb 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Xylocaine spray 100mg/ml

Topical application

Diagnostic Test: Xylocaine spray 100mg/ml
Topical application

Placebo Comparator: Ethanol

Topical application

Diagnostic Test: Ethanol
Topical application

Outcome Measures

Primary Outcome Measures

  1. Paradoxical heat sensation (PHS) [45 minutes]

    Number of PHS responders on arm treated with lidocaine 45 minutes after drug application and Number of PHS responders on arm treated with ethanol 45 minutes after drug application

Secondary Outcome Measures

  1. Thermal Grill (TG) [75 minutes]

    Number of TG responders on arm treated with lidocaine 75 minutes after drug application and Number of TG responders on arm treated with ethanol 75 minutes after drug application

  2. Quality of the Thermal Grill (TG) [75 minutes]

    The participants are asked whether the stimulus is burning, hot, warm, neutral, cold, or freezing cold after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 75 minutes after drug application The participants are asked whether the stimulus is burning, hot, warm, neutral, cold, or freezing cold after the TG-condition (warm and cold) or only warm or only cold on arm treated with ethanol 75 minutes after drug application

  3. Pain intensity of the Thermal Grill (TG) [90 minutes]

    The participants are asked to rate the intensity of pain on a visual analog scale (VAS) 0-100 (0 no pain; 100 worst pain imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 90 minutes after drug application The participants are asked to rate the intensity of pain on a VAS 0-100 (0 no pain; 100 worst pain imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 90 minutes after drug application

  4. Intensity of unpleasantness of the Thermal Grill (TG) [95 minutes]

    The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no unpleasantness; 100 worst unpleasantness imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 95 minutes after drug application The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no unpleasantness; 100 worst unpleasantness imaginable) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 95 minutes after drug application

  5. Intensity of cold of the Thermal Grill (TG) [95 minutes]

    The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no cold; 100 extremely cold ) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 95 minutes after drug application The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no cold; 100 extremely cold ) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 95 minutes after drug application

  6. Intensity of warm of the Thermal Grill (TG) [95 minutes]

    The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no warm; 100 extremely warm ) after the TG-condition (warm and cold), only warm or only cold on arm treated with lidocaine 95 minutes after drug application The participants are asked to rate the intensity of unpleasantness on a VAS 0-100 (0 no warm; 100 extremely warm ) after the TG-condition (warm and cold), only warm or only cold on arm treated with ethanol 95 minutes after drug application

  7. Paradoxical heat sensation (PHS) [30 minutes before drug application]

    Number of PHS responders at baseline without any treatment, 30 minutes before drug application

  8. Thermal Grill (TG) [20 minutes before drug application]

    Number of TG responders at baseline without any treatment 20 minutes before drug application

Other Outcome Measures

  1. Thermal thresholds [45 minutes]

    Detection- and pain thresholds for cold, warm (degrees) stimuli at baseline without any treatment Detection- and pain thresholds for cold, warm (degrees) stimuli on arm treated with lidocaine 45 minutes after drug application Detection- and pain thresholds for cold, warm (degrees) stimuli on arm treated with ethanol 45 minutes after drug application

  2. Paradoxical heat sensation (PHS) using a modified protocol [100 minutes]

    Number of PHS responders if the skin is heated or cooled prior the test at baseline without any treatment Number of PHS responders if the skin is heated or cooled prior the test on arm treated with lidocaine 100 minutes after drug application Number of PHS responders if the skin is heated or cooled prior the test on arm treated with ethanol 100 minutes after drug application

  3. Mechanical thresholds [45 minutes]

    Detection- and pain thresholds for mechanical (mNewton) stimuli at baseline without any treatment Detection- and pain thresholds for mechanical (mNewton) stimuli on arm treated with lidocaine 45 minutes after drug application Detection- and pain thresholds for mechanical (mNewton) stimuli on arm treated with ethanol 45 minutes after drug application

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy subjects

  • Age between 18 and 40 years

  • Participant is able and willing to give informed consent.

Exclusion Criteria:
  • Unable to understand and speak Danish

  • Non-cooperative

  • Chronic pain or acute pain the past week lasting more than 4 hours or pain on the day of investigation

  • Pain medication within the last week

  • Medication within the last week that can affect assessment

  • Psychiatric or neurological disease and diseases that may affect the assessment

  • Sensory disturbances

  • History or symptoms of significant diseases (e.g. psychiatric or neurological disease, diseases that may affect the assessment, sensory disturbances, cancer, diabetes mellitus, liver diseases, kidney diseases, cardiovascular diseases)

  • Pregnancy or lactation

  • Jetlag or sleep deprivation

  • Alcohol or drug abuse

  • Consumption of cannabis the last 4 weeks and consumption of alcohol in the last 48 hours

  • Any abnormality of the skin or of vascular origin at application site

  • History of hypersensitivity to lidocaine, other amide-type anesthetics, or other contents of the lidocaine or vehicle

Contacts and Locations

Locations

Site City State Country Postal Code
1 Danish Pain Research Center, Aarhus University, Aarhus University Hospital Aarhus N Denmark 8200

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Principal Investigator: Ellen L Schaldemose, MD, Danish Pain Research Center, Aarhus University

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT04865185
Other Study ID Numbers:
  • TLH21
First Posted:
Apr 29, 2021
Last Update Posted:
Apr 29, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Aarhus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 29, 2021